JP2022535290A5 - - Google Patents
Info
- Publication number
- JP2022535290A5 JP2022535290A5 JP2021572425A JP2021572425A JP2022535290A5 JP 2022535290 A5 JP2022535290 A5 JP 2022535290A5 JP 2021572425 A JP2021572425 A JP 2021572425A JP 2021572425 A JP2021572425 A JP 2021572425A JP 2022535290 A5 JP2022535290 A5 JP 2022535290A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridine
- oxadiazole
- trifluoromethyl
- pyrrolo
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382475.2 | 2019-06-06 | ||
| EP19382475 | 2019-06-06 | ||
| EP19383221.9 | 2019-12-31 | ||
| EP19383221 | 2019-12-31 | ||
| PCT/EP2020/065658 WO2020245381A1 (en) | 2019-06-06 | 2020-06-05 | 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535290A JP2022535290A (ja) | 2022-08-05 |
| JP2022535290A5 true JP2022535290A5 (https=) | 2023-06-13 |
| JP7523146B2 JP7523146B2 (ja) | 2024-07-26 |
Family
ID=71083614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572425A Active JP7523146B2 (ja) | 2019-06-06 | 2020-06-05 | Ｈｄａｃ６阻害薬としての３－（２－（ヘテロアリール）－ピリジン－４－イル）－５－（トリフルオロメチル）－１，２，４－オキサジアゾール誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12522598B2 (https=) |
| EP (1) | EP3980416B1 (https=) |
| JP (1) | JP7523146B2 (https=) |
| CN (1) | CN114206868B (https=) |
| CA (1) | CA3142435A1 (https=) |
| MX (1) | MX2021014918A (https=) |
| WO (1) | WO2020245381A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| AU2020321955A1 (en) | 2019-07-30 | 2022-03-17 | Eikonizo Therapapeutics, Inc. | HDAC6 inhibitors and uses thereof |
| TW202345813A (zh) | 2022-04-08 | 2023-12-01 | 美商艾科尼佐療法股份有限公司 | 㗁二唑ｈｄａｃ６抑制劑及其用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8101618B2 (en) | 2005-04-06 | 2012-01-24 | Msd K.K. | 1,4-substituted piperazine derivatives |
| US20100136024A1 (en) | 2008-11-14 | 2010-06-03 | Bartels Stephen P | Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma |
| NZ610225A (en) | 2010-11-16 | 2015-08-28 | Acetylon Pharmaceuticals Inc | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| WO2013066839A2 (en) | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
| BR112014012815A8 (pt) | 2011-11-28 | 2017-06-20 | Novartis Ag | derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença |
| US10081624B2 (en) | 2014-08-26 | 2018-09-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JPWO2017014170A1 (ja) | 2015-07-17 | 2018-04-26 | 武田薬品工業株式会社 | 複素環化合物 |
| AU2016297362B2 (en) | 2015-07-17 | 2020-04-16 | Takeda Pharmaceutical Company Limited | Oxadiazole derivatives useful as HDAC inhibitors |
| WO2017033946A1 (ja) | 2015-08-25 | 2017-03-02 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2017161033A1 (en) | 2016-03-15 | 2017-09-21 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| WO2017222952A1 (en) * | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| WO2017222951A1 (en) * | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| WO2017222950A1 (en) | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3-heterocyclyl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| WO2018118781A1 (en) | 2016-12-20 | 2018-06-28 | Fmc Corporation | Fungicidal oxadiazoles |
| SG11202005254RA (en) * | 2017-12-05 | 2020-07-29 | Oryzon Genomics Sa | 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors |
-
2020
- 2020-06-05 WO PCT/EP2020/065658 patent/WO2020245381A1/en not_active Ceased
- 2020-06-05 US US17/596,048 patent/US12522598B2/en active Active
- 2020-06-05 CN CN202080055779.0A patent/CN114206868B/zh active Active
- 2020-06-05 CA CA3142435A patent/CA3142435A1/en active Pending
- 2020-06-05 EP EP20732166.2A patent/EP3980416B1/en active Active
- 2020-06-05 MX MX2021014918A patent/MX2021014918A/es unknown
- 2020-06-05 JP JP2021572425A patent/JP7523146B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535290A5 (https=) | ||
| RU2007139255A (ru) | Новые оксадиазольные производные и их медицинское применение | |
| JP5450434B2 (ja) | 関節炎の治療方法 | |
| AU2006281334B2 (en) | Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same | |
| JP2018501315A5 (https=) | ||
| RU2011116230A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| CN108864151A (zh) | 杂环胺及其用途 | |
| JP2006520805A5 (https=) | ||
| JP2012510989A5 (https=) | ||
| JP2003512374A5 (https=) | ||
| JP2013505930A5 (https=) | ||
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2011520981A5 (https=) | ||
| JP2003513071A5 (https=) | ||
| CN105246485B (zh) | α7烟碱型乙酰胆碱受体激动剂的应用 | |
| MX2007011436A (es) | Ligando del receptor nicotinico neuronal 7 y composiciones antipsicoticas. | |
| CA2555172A1 (en) | Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders | |
| JP2005508872A5 (https=) | ||
| JP2018522062A5 (https=) | ||
| US20140221385A1 (en) | Combinations of serotonin receptor agonists for treatment of movement disorders | |
| JP2022534434A5 (https=) | ||
| CN101198323A (zh) | 用于治疗或预防精神障碍的治疗组合 | |
| JP2022527618A5 (https=) | ||
| RU2006125636A (ru) | Лиганды никотиновых рецепторов ацетилхолина | |
| JP2015526475A5 (https=) |